CA2758247A1 - Herbicide resistant camelina sativa - Google Patents
Herbicide resistant camelina sativa Download PDFInfo
- Publication number
- CA2758247A1 CA2758247A1 CA2758247A CA2758247A CA2758247A1 CA 2758247 A1 CA2758247 A1 CA 2758247A1 CA 2758247 A CA2758247 A CA 2758247A CA 2758247 A CA2758247 A CA 2758247A CA 2758247 A1 CA2758247 A1 CA 2758247A1
- Authority
- CA
- Canada
- Prior art keywords
- als
- plant
- seq
- gene
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000004009 herbicide Substances 0.000 title claims abstract description 79
- 244000197813 Camelina sativa Species 0.000 title claims abstract description 61
- 230000002363 herbicidal effect Effects 0.000 title claims abstract description 43
- 235000014595 Camelina sativa Nutrition 0.000 title abstract description 35
- 241000196324 Embryophyta Species 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 11
- 238000000338 in vitro Methods 0.000 claims abstract description 9
- 108010000700 Acetolactate synthase Proteins 0.000 claims description 58
- 230000009261 transgenic effect Effects 0.000 claims description 49
- 230000035772 mutation Effects 0.000 claims description 32
- 101150001232 ALS gene Proteins 0.000 claims description 30
- 230000009466 transformation Effects 0.000 claims description 30
- 108090000623 proteins and genes Proteins 0.000 claims description 25
- 241000219195 Arabidopsis thaliana Species 0.000 claims description 13
- 239000002773 nucleotide Substances 0.000 claims description 12
- 125000003729 nucleotide group Chemical group 0.000 claims description 12
- 108091026890 Coding region Proteins 0.000 claims description 7
- 108700039691 Genetic Promoter Regions Proteins 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 4
- 102000018673 SEC Translocation Channels Human genes 0.000 claims description 4
- 108010091732 SEC Translocation Channels Proteins 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 3
- 230000008929 regeneration Effects 0.000 abstract description 5
- 238000011069 regeneration method Methods 0.000 abstract description 5
- 238000010367 cloning Methods 0.000 description 25
- 229940100389 Sulfonylurea Drugs 0.000 description 21
- 239000012634 fragment Substances 0.000 description 19
- 108091008146 restriction endonucleases Proteins 0.000 description 19
- UWHURBUBIHUHSU-UHFFFAOYSA-N 2-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)carbamoylsulfamoyl]benzoic acid Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 UWHURBUBIHUHSU-UHFFFAOYSA-N 0.000 description 17
- 239000005496 Chlorsulfuron Substances 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 16
- 239000013598 vector Substances 0.000 description 16
- 101150084750 1 gene Proteins 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- 101150100395 ALS1 gene Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 239000002689 soil Substances 0.000 description 6
- 108020005345 3' Untranslated Regions Proteins 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 5
- 240000004674 Papaver rhoeas Species 0.000 description 5
- 235000007846 Papaver rhoeas Nutrition 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 4
- 235000016401 Camelina Nutrition 0.000 description 4
- 108020005120 Plant DNA Proteins 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000005030 transcription termination Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 108020004518 RNA Probes Proteins 0.000 description 3
- 239000003391 RNA probe Substances 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 108700019146 Transgenes Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 244000038559 crop plants Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 3
- 229960004659 ticarcillin Drugs 0.000 description 3
- RBSXHDIPCIWOMG-UHFFFAOYSA-N 1-(4,6-dimethoxypyrimidin-2-yl)-3-(2-ethylsulfonylimidazo[1,2-a]pyridin-3-yl)sulfonylurea Chemical compound CCS(=O)(=O)C=1N=C2C=CC=CN2C=1S(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 RBSXHDIPCIWOMG-UHFFFAOYSA-N 0.000 description 2
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- NUPJIGQFXCQJBK-UHFFFAOYSA-N 2-(4-isopropyl-4-methyl-5-oxo-4,5-dihydro-1H-imidazol-2-yl)-5-(methoxymethyl)nicotinic acid Chemical compound OC(=O)C1=CC(COC)=CN=C1C1=NC(C)(C(C)C)C(=O)N1 NUPJIGQFXCQJBK-UHFFFAOYSA-N 0.000 description 2
- PRZRAMLXTKZUHF-UHFFFAOYSA-N 5-oxo-n-sulfonyl-4h-triazole-1-carboxamide Chemical class O=S(=O)=NC(=O)N1N=NCC1=O PRZRAMLXTKZUHF-UHFFFAOYSA-N 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 2
- 241000219194 Arabidopsis Species 0.000 description 2
- 101100179609 Arabidopsis thaliana ALS gene Proteins 0.000 description 2
- 235000005688 Camelina microcarpa Nutrition 0.000 description 2
- 241001234743 Camelina microcarpa Species 0.000 description 2
- 241000701489 Cauliflower mosaic virus Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 206010064571 Gene mutation Diseases 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 239000005566 Imazamox Substances 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 101150072210 SEC61 gene Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000009418 agronomic effect Effects 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000013599 cloning vector Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTLNOANVTIKPEE-UHFFFAOYSA-N 2-acetyloxypropanoic acid Chemical class OC(=O)C(C)OC(C)=O WTLNOANVTIKPEE-UHFFFAOYSA-N 0.000 description 1
- CDUVSERIDNVFDD-UHFFFAOYSA-N 2-pyrimidin-2-ylbenzenecarbothioic s-acid Chemical class OC(=S)C1=CC=CC=C1C1=NC=CC=N1 CDUVSERIDNVFDD-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 101100161479 Arabidopsis thaliana ABCB27 gene Proteins 0.000 description 1
- 101000852723 Arabidopsis thaliana Acetolactate synthase small subunit 1, chloroplastic Proteins 0.000 description 1
- 101000852721 Arabidopsis thaliana Acetolactate synthase small subunit 2, chloroplastic Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 229920002271 DEAE-Sepharose Polymers 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 108010091873 DyNAzyme polymerase Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 101000664887 Homo sapiens Superoxide dismutase [Cu-Zn] Proteins 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000005584 Metsulfuron-methyl Substances 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005089 Plant RNA Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000005604 Prosulfuron Substances 0.000 description 1
- LTUNNEGNEKBSEH-UHFFFAOYSA-N Prosulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)CCC(F)(F)F)=N1 LTUNNEGNEKBSEH-UHFFFAOYSA-N 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000409648 Sisymbrieae Species 0.000 description 1
- 239000005619 Sulfosulfuron Substances 0.000 description 1
- 102100038836 Superoxide dismutase [Cu-Zn] Human genes 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108700026226 TATA Box Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 239000005626 Tribenuron Substances 0.000 description 1
- 240000000359 Triticum dicoccon Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003525 auxine Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000002551 biofuel Substances 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- RSMUVYRMZCOLBH-UHFFFAOYSA-N metsulfuron methyl Chemical group COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(C)=NC(OC)=N1 RSMUVYRMZCOLBH-UHFFFAOYSA-N 0.000 description 1
- 238000007479 molecular analysis Methods 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 102200111112 rs397514590 Human genes 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- JRQGDDUXDKCWRF-UHFFFAOYSA-M sodium;n-(2-methoxycarbonylphenyl)sulfonyl-4-methyl-5-oxo-3-propoxy-1,2,4-triazole-1-carboximidate Chemical compound [Na+].O=C1N(C)C(OCCC)=NN1C(=O)[N-]S(=O)(=O)C1=CC=CC=C1C(=O)OC JRQGDDUXDKCWRF-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- BQZXUHDXIARLEO-UHFFFAOYSA-N tribenuron Chemical compound COC1=NC(C)=NC(N(C)C(=O)NS(=O)(=O)C=2C(=CC=CC=2)C(O)=O)=N1 BQZXUHDXIARLEO-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8274—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for herbicide resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
This disclosure provides a novel herbicide resistant plant, a method to transform Camelina sativa for herbicide resistance and a method for an improved in vitro regeneration of transformed plants.
Description
Title: Herbicide resistant Camelina sativa Field of the Invention This invention relates to herbicide resistant crop plants. More specifically this invention relates to herbicide resistant Camelina sativa plants.
Background of the invention Camelina sativa (L. Crantz) belongs to the family Brassicaceae in the tribe Sisymbrieae and both spring- and winter forms are in production. It is a low-input crop adapted to low fertility soils. Results from long-term experiments in Central Europe have shown that the seed yields of Camelina sativa are comparable to the yields of oil seed rape.
As Camelina sativa is a minor crop species, very little has been done in terms of its breeding aside from testing different accessions for agronomic traits and oil profiles.
However, due to the high oil content of Camelina sativa seeds (varying between 30 - 40%), there has been a renewed interest in Camelina sativa oil. Camelina sativa seeds have high content of polyunsaturated fatty acids, about 50 -60% with an excellent balance of useful fatty acids including 30 - 40% of alpha-linolenic acid, which is omega- 3 oil. Omega- 3 oils from plants metabolically resemble marine omega-3oils and are rarely found in other seed crops. Furthermore, Camelina sativa seeds contain high amount of tocopherols (appr. 600 ppm) with a unique oxidative stability. Moreover, there is an increasing interest in Camelina sativa as animal feed.
In addition, there is an impeding need to introduce commercial crops to provide vegetable oils for biofuel production without displacing food crops from rich soils. Because Camelina sativa is well suited to marginal soils, this plant species offers an alternative crop that can be grown and harvested in large quantities. However, because of limited breeding success, improvements in Camelina sativa, such as herbicide resistance, increased protein quality, increased oil content, and enhanced agronomic characteristics are lacking.
Many herbicides used in grain production (e.g. wheat) can carry over, resulting in loss of Camelina yields. Herbicides commonly used in the Pacific Northwest America are listed in Table 1 below. Areas where these herbicides are used cannot be used for Camelina cultivation before herbicide residues are degraded. Factors that affect degradation include climate factors such as moisture, and temperature as well as soil pH. In Pacific Northwest America the period that the soil contains herbicide residues may last several years.
Table 1. Herbicides commonly used in the Pacific Northwest America Sulfuronic herbicide Clorsulfuron (Glean(g) Metsulfuron (Ally ) Tiasulfuron (Amber ) Prosulfuron (Peak ) Thfensulfuron combined with tribenuron
Background of the invention Camelina sativa (L. Crantz) belongs to the family Brassicaceae in the tribe Sisymbrieae and both spring- and winter forms are in production. It is a low-input crop adapted to low fertility soils. Results from long-term experiments in Central Europe have shown that the seed yields of Camelina sativa are comparable to the yields of oil seed rape.
As Camelina sativa is a minor crop species, very little has been done in terms of its breeding aside from testing different accessions for agronomic traits and oil profiles.
However, due to the high oil content of Camelina sativa seeds (varying between 30 - 40%), there has been a renewed interest in Camelina sativa oil. Camelina sativa seeds have high content of polyunsaturated fatty acids, about 50 -60% with an excellent balance of useful fatty acids including 30 - 40% of alpha-linolenic acid, which is omega- 3 oil. Omega- 3 oils from plants metabolically resemble marine omega-3oils and are rarely found in other seed crops. Furthermore, Camelina sativa seeds contain high amount of tocopherols (appr. 600 ppm) with a unique oxidative stability. Moreover, there is an increasing interest in Camelina sativa as animal feed.
In addition, there is an impeding need to introduce commercial crops to provide vegetable oils for biofuel production without displacing food crops from rich soils. Because Camelina sativa is well suited to marginal soils, this plant species offers an alternative crop that can be grown and harvested in large quantities. However, because of limited breeding success, improvements in Camelina sativa, such as herbicide resistance, increased protein quality, increased oil content, and enhanced agronomic characteristics are lacking.
Many herbicides used in grain production (e.g. wheat) can carry over, resulting in loss of Camelina yields. Herbicides commonly used in the Pacific Northwest America are listed in Table 1 below. Areas where these herbicides are used cannot be used for Camelina cultivation before herbicide residues are degraded. Factors that affect degradation include climate factors such as moisture, and temperature as well as soil pH. In Pacific Northwest America the period that the soil contains herbicide residues may last several years.
Table 1. Herbicides commonly used in the Pacific Northwest America Sulfuronic herbicide Clorsulfuron (Glean(g) Metsulfuron (Ally ) Tiasulfuron (Amber ) Prosulfuron (Peak ) Thfensulfuron combined with tribenuron
2 (Harmony Extra ) Sulfosulfuron (Maverick ) Imidazolinones Imazamox (Beyond ) Sulfonylamino-carbonyl-triazolinones Propoxycarbazone-sodium (Olympus ) This invention is aimed to resolve the existing problems: creating an herbicide resistant Camelina sativa line would allow access for Camelina cultivation in areas, where growing Camelina will offer a cropping choice in areas in which choices for rotation crops are limited.
Moreover, this invention is aimed to provide herbicide resistant Camelina sativa plants and cultivars.
Short description of the figures Fig. 1 illustrates the procedure for DNA cloning.
Fig. 2 illustrates cloning of plant transformation vector for ALS constructs used in this disclosure Fig. 3 illustrates cloning of Arabidopsis thaliana (A.t) ALS1-gene and regions up- and down-stream from the gene.
Fig. 4 illustrates cloning of pC0300-P-At-ALS containing ALS promoter region of Arabidopsis thaliana.
Fig. 5 illustrates cloning of pC0300-PT-At-ALS construct containing promoter region (P) and transcription termination region (T) of ALS gene.
Moreover, this invention is aimed to provide herbicide resistant Camelina sativa plants and cultivars.
Short description of the figures Fig. 1 illustrates the procedure for DNA cloning.
Fig. 2 illustrates cloning of plant transformation vector for ALS constructs used in this disclosure Fig. 3 illustrates cloning of Arabidopsis thaliana (A.t) ALS1-gene and regions up- and down-stream from the gene.
Fig. 4 illustrates cloning of pC0300-P-At-ALS containing ALS promoter region of Arabidopsis thaliana.
Fig. 5 illustrates cloning of pC0300-PT-At-ALS construct containing promoter region (P) and transcription termination region (T) of ALS gene.
3 Fig. 6 illustrates cloning of pC0300-T-At-ALS without promoter region.
Fig. 7 illustrates cloning of pC0300-P35S-At-ALS plant transformation vector containing 35S
promoter of Cauliflower Mosaic Virus and Transcription termination region of the ALS gene of Arabidopsis thaliana.
Fig. 8 illustrates cloning of pVK1-At-ALS containing coding region of ALS gene amplified in PCR on genomic DNA of Arabidopsis thaliana.
Fig. 9 illustrates cloning of Papaver rhoeas ALS 3'UTR downstream ofA.t. ALS1-gene in pVKI
cloning vector.
Fig. 10 illustrates mutagenesis of Arabidopsis thaliana ALS 1 gene.
Fig. 11 illustrates cloning of mutated ALS 1 gene into plant transformation vectors.
Fig. 12 illustrates the mutation (removal) of SEC61 putative TATA-boxes Fig. 13 In vitro leaf segment test of two transgenic C. sativa cv. Celine lines VK6-AI-No24 (shown as 24 on Petri dishes) and VK6-Al-No26 (shown as 26 on Petri dishes). As a control, leaf segments of herbicide resistant natural mutant of Camelina microcarpa (C.m.) and leaf segments of susceptible C.
sativa (C.s.) were used. Leaf segments of transgenic plants are resistant to the herbicides, while non-
Fig. 7 illustrates cloning of pC0300-P35S-At-ALS plant transformation vector containing 35S
promoter of Cauliflower Mosaic Virus and Transcription termination region of the ALS gene of Arabidopsis thaliana.
Fig. 8 illustrates cloning of pVK1-At-ALS containing coding region of ALS gene amplified in PCR on genomic DNA of Arabidopsis thaliana.
Fig. 9 illustrates cloning of Papaver rhoeas ALS 3'UTR downstream ofA.t. ALS1-gene in pVKI
cloning vector.
Fig. 10 illustrates mutagenesis of Arabidopsis thaliana ALS 1 gene.
Fig. 11 illustrates cloning of mutated ALS 1 gene into plant transformation vectors.
Fig. 12 illustrates the mutation (removal) of SEC61 putative TATA-boxes Fig. 13 In vitro leaf segment test of two transgenic C. sativa cv. Celine lines VK6-AI-No24 (shown as 24 on Petri dishes) and VK6-Al-No26 (shown as 26 on Petri dishes). As a control, leaf segments of herbicide resistant natural mutant of Camelina microcarpa (C.m.) and leaf segments of susceptible C.
sativa (C.s.) were used. Leaf segments of transgenic plants are resistant to the herbicides, while non-
4 transgenic Camelina sativa is susceptible. The media in Petri dishes contains herbicides in various concentrations from 0 mg/l in control plate to 0.001, 0.01, 0.1, 1.0 mg/l of IMI, MSU and CSU.
Fig. 14 IMI and MSU 10 day-tests applied to the shoots recovered after transformation of Blane Creek.
Green and well-developed shoots are most evidently transgenic with good expression of the mutant ALS gene. Such shoots were transferred to fresh MS agar with the same herbicides to prove the resistance of the shoots.
Fig. 15. Shows a Southern Analysis blot of ten transgenic ALS-carrying plants (columns 1-10).
Column 11 presents plasmid DNA carrying the gene sequence, cut with restriction enzymes and mixed with non-transgenic plant DNA as positive control (BC + M). Column 12 presents a negative control being DNA of non-transgenic Camelina sativa plant DNA mixed with 1 kb Marker (Fermentas) (BC +
1 kb M). The line does not show any signal.
Figure 16A shows seedlings of transgenic lines bearing triple (APW) mutated ALS gene: ALS 11.3 (VK10A5.3) and ALS22.3 (VK13A15.12) of the fourth generation (T3) of Camelina sativa v. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16B shows seedlings of transgenic lines bearing double (PW) mutated ALS
gene: ALS7.3 (KK24A14.4) ALS8.3 (KK18A8) of fourth generation (T3) of Camelina sativa v.
Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the growth media.
Fig. 14 IMI and MSU 10 day-tests applied to the shoots recovered after transformation of Blane Creek.
Green and well-developed shoots are most evidently transgenic with good expression of the mutant ALS gene. Such shoots were transferred to fresh MS agar with the same herbicides to prove the resistance of the shoots.
Fig. 15. Shows a Southern Analysis blot of ten transgenic ALS-carrying plants (columns 1-10).
Column 11 presents plasmid DNA carrying the gene sequence, cut with restriction enzymes and mixed with non-transgenic plant DNA as positive control (BC + M). Column 12 presents a negative control being DNA of non-transgenic Camelina sativa plant DNA mixed with 1 kb Marker (Fermentas) (BC +
1 kb M). The line does not show any signal.
Figure 16A shows seedlings of transgenic lines bearing triple (APW) mutated ALS gene: ALS 11.3 (VK10A5.3) and ALS22.3 (VK13A15.12) of the fourth generation (T3) of Camelina sativa v. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16B shows seedlings of transgenic lines bearing double (PW) mutated ALS
gene: ALS7.3 (KK24A14.4) ALS8.3 (KK18A8) of fourth generation (T3) of Camelina sativa v.
Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the growth media.
5
6 PCT/US2010/001704 Figure 16C shows seedlings of transgenic lines bearing A-mutated ALS gene: A3 (VK9A3.4.1) of the second generation (T 1) of Camel ina sativa v. Calena, as well as A9.1 (VK
14A9.1) and A9.2 (VK14A9.4.2) of the second generation (Ti) Camelina sativa v. Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI.
The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16 D shows seedlings of transgenic lines bearing P-mutated ALS gene: A4 (VK9A4.4.2) of the second generation (Ti) of Camelina sativa v. Calena and A10 (VK14A10.16) of the second generation (Ti) Camelina sativa c. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l.
Figure 16 E shows seedlings of transgenic lines bearing W-mutated ALS gene: A2 (VK10A2.2) of the second generation (Ti) of Camelina sativa v. Blane Creek and ALS23.3 (VK10A2.3) of the fourth generation (T3) of Camelina sativa v. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16 F shows seedlings of wild type control seeds of Camelina sativa c.
Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Description of the invention The present invention provides methods for producing novel Camelina plants and cultivars resistant to herbicides. In particular, the present invention provides novel Camelina plants, tissues and seeds that contain modified acetolactate synthase (ALS) genes and proteins that are resistant to inhibition by herbicides that normally inhibit ALS enzyme.
ALS-targeting herbicides inhibit acetolactate synthase (ALS), which is required for production of essential branched-chain amino acids such as valine, leucine, and isoleucine.
The five chemical classes of ALS-inhibiting herbicides are sulfonylureas (SU), imidazolinones (IMI), triazolopyrimidines (TP), pyrimidinylthiobenzoates (PTB), and sulfonylamino-carbonyl-triazolinones (SCT). Mutations in some crop plants, for example tobacco, corn and soybean have been found conferring ALS herbicide resistance in those plants. As Camelina sativa has not been a major crop plant, such information is not available for it.
ALS -inhibiting herbicides control a wide spectrum of grass and broad leaf weeds at very low application rates. As is shown in Table 1, the commonly used herbicides in Pacific Northwest in the United States of America to control weeds are members of ALS herbicides.
Accordingly, this invention provides Camelina plants resistant to ALS-inhibiting herbicides, thereby providing cultivars for large-scale production in this area.
There are various ALS mutants in the nature (e.g. ALS mutant has been documented in Arabidopsis thaliana); however, in conditions where herbicides are not present the mutant enzymes do not function as effectively as normal ALS enzymes. This fact causes cost for fitness for mutated plants in the field.
This disclosure provides transgenic Camelina sativa lines that are transformed with artificial ALS
14A9.1) and A9.2 (VK14A9.4.2) of the second generation (Ti) Camelina sativa v. Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI.
The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16 D shows seedlings of transgenic lines bearing P-mutated ALS gene: A4 (VK9A4.4.2) of the second generation (Ti) of Camelina sativa v. Calena and A10 (VK14A10.16) of the second generation (Ti) Camelina sativa c. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l.
Figure 16 E shows seedlings of transgenic lines bearing W-mutated ALS gene: A2 (VK10A2.2) of the second generation (Ti) of Camelina sativa v. Blane Creek and ALS23.3 (VK10A2.3) of the fourth generation (T3) of Camelina sativa v. Blane Creek. The seedlings were grown one week on various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Figure 16 F shows seedlings of wild type control seeds of Camelina sativa c.
Blane Creek. The seedlings were grown one week on the various concentrations of herbicides MSU, CSU and IMI. The concentrations are shown in mg/l. Control plate has no herbicide in the grown media.
Description of the invention The present invention provides methods for producing novel Camelina plants and cultivars resistant to herbicides. In particular, the present invention provides novel Camelina plants, tissues and seeds that contain modified acetolactate synthase (ALS) genes and proteins that are resistant to inhibition by herbicides that normally inhibit ALS enzyme.
ALS-targeting herbicides inhibit acetolactate synthase (ALS), which is required for production of essential branched-chain amino acids such as valine, leucine, and isoleucine.
The five chemical classes of ALS-inhibiting herbicides are sulfonylureas (SU), imidazolinones (IMI), triazolopyrimidines (TP), pyrimidinylthiobenzoates (PTB), and sulfonylamino-carbonyl-triazolinones (SCT). Mutations in some crop plants, for example tobacco, corn and soybean have been found conferring ALS herbicide resistance in those plants. As Camelina sativa has not been a major crop plant, such information is not available for it.
ALS -inhibiting herbicides control a wide spectrum of grass and broad leaf weeds at very low application rates. As is shown in Table 1, the commonly used herbicides in Pacific Northwest in the United States of America to control weeds are members of ALS herbicides.
Accordingly, this invention provides Camelina plants resistant to ALS-inhibiting herbicides, thereby providing cultivars for large-scale production in this area.
There are various ALS mutants in the nature (e.g. ALS mutant has been documented in Arabidopsis thaliana); however, in conditions where herbicides are not present the mutant enzymes do not function as effectively as normal ALS enzymes. This fact causes cost for fitness for mutated plants in the field.
This disclosure provides transgenic Camelina sativa lines that are transformed with artificial ALS
7 enzyme variations giving resistance to IMI and SU herbicides. The transgenic plants according to this invention, do not suffer fitness cost, because they have their normal ALS
enzymes functional in conditions where herbicide is not present. The additional transgenic ALS
mutant works during herbicide contact and allows survival of the plant in those conditions.
This invention discloses use of Arabidopsis thaliana (A. t) ALS natural gene cassette comprising promoter, gene coding region and terminator region in creating the transgenic Camelina plants.
Because Arabidopsis thaliana has only a single ALS gene per genome, it is functional in all organs and development stages. Although the ALS promoter is strong enough to confer sufficient enzymatic activity with one gene copy only, we have also chosen to use the 35S as an alternative promoter strategy because it strongly and constitutively (ubiquitously) expresses ALS
in various organs. We also have used so-called TATA-less pALS (or -TATA) promoters as an alternative to natural Arabidopsis thaliana ALS promoter, because the natural promoter contains an extra small gene that encodes an additional small protein. In our -TATA constructs, this additional small gene is made non-functional by deleting TATA-box element from the promoter of extra gene.
Herbicide - ALS binding is dependent on specific 3D structures of the herbicide and of ALS protein.
Generally speaking, protein structure can be changed by mutating its amino acids. Resistance to ALS-inhibiting herbicides is formed by mutated 3D structure of ALS protein and reduced binding of specific herbicide chemical to certain area of the protein. We chose to use three kinds of point mutations in the natural Arabidopsis thaliana ALS-gene in the constructs that are used to transform Camelina plants (Table 2).
enzymes functional in conditions where herbicide is not present. The additional transgenic ALS
mutant works during herbicide contact and allows survival of the plant in those conditions.
This invention discloses use of Arabidopsis thaliana (A. t) ALS natural gene cassette comprising promoter, gene coding region and terminator region in creating the transgenic Camelina plants.
Because Arabidopsis thaliana has only a single ALS gene per genome, it is functional in all organs and development stages. Although the ALS promoter is strong enough to confer sufficient enzymatic activity with one gene copy only, we have also chosen to use the 35S as an alternative promoter strategy because it strongly and constitutively (ubiquitously) expresses ALS
in various organs. We also have used so-called TATA-less pALS (or -TATA) promoters as an alternative to natural Arabidopsis thaliana ALS promoter, because the natural promoter contains an extra small gene that encodes an additional small protein. In our -TATA constructs, this additional small gene is made non-functional by deleting TATA-box element from the promoter of extra gene.
Herbicide - ALS binding is dependent on specific 3D structures of the herbicide and of ALS protein.
Generally speaking, protein structure can be changed by mutating its amino acids. Resistance to ALS-inhibiting herbicides is formed by mutated 3D structure of ALS protein and reduced binding of specific herbicide chemical to certain area of the protein. We chose to use three kinds of point mutations in the natural Arabidopsis thaliana ALS-gene in the constructs that are used to transform Camelina plants (Table 2).
8 Table 2. Three kinds of point mutations of Arabidopsis thaliana ALS gene were selected for the constructs for transforming Camelina plants. Mutations are named according to type and sequence number of changed amino acid: A122 (Ala 122), P197 (Pro 197) and W574 (Trp574).
Promoter ALS gene mutation Resistance pALS 1. Ala 122 > Thr IMI
pALS 2. Pro 197 > Ser SU
pALS 3. Trp 574 > Leu IMI + SU
pALS 4. Ala 122 > Thr and Pro 197 > Ser IMI + SU
pALS 5. Ala 122 > Thr and Trp 574 > Leu IMI + SU
pALS 6. Pro 197 > Ser and Trp 574 > Leu IMI + SU
pALS 7. Ala 122 > Thr and Pro 197 > Ser and T 574 > Leu IMI + SU
ALS - TATA 1. Trp 574 > Leu IMI +SU
ALS -TATA 2. Ala 122 > Thr IMI +SU
pALS-TATA 3. Pro 197 > Ser IMI +SU
ALS -TATA 4. Ala 122 > Thr and Pro 197 > Ser IMI +SU
pALS-TATA 5. Ala 122 > Thr and Trp 574 > Leu IMI +SU
pALS-TATA 6. Pro 197 > Ser and Trp 574 > Leu IMI +SU
ALS -TATA 7. Ala 122 > Thr and Pro 197 > Ser and Trp 574 > Leu IMI +SU
35S Trp 574 > Leu IMI +SU
In the transformation procedure we used a PC0300 plant transformation vector.
We have removed all needless DNA sequences from T-DNA of the vector. Therefore, only some nucleotides from bacterial T-DNA borders are left. Moreover, no antibiotic resistance genes were used in transformation. As a result, only plant natural ALS sequences containing engineered point-mutations are transferred into the plant.
EXAMPLE 1. DNA cloning Figure 1 illustrates the scheme of cloning plant transformation vectors containing ALS gene according to this disclosure.
Promoter ALS gene mutation Resistance pALS 1. Ala 122 > Thr IMI
pALS 2. Pro 197 > Ser SU
pALS 3. Trp 574 > Leu IMI + SU
pALS 4. Ala 122 > Thr and Pro 197 > Ser IMI + SU
pALS 5. Ala 122 > Thr and Trp 574 > Leu IMI + SU
pALS 6. Pro 197 > Ser and Trp 574 > Leu IMI + SU
pALS 7. Ala 122 > Thr and Pro 197 > Ser and T 574 > Leu IMI + SU
ALS - TATA 1. Trp 574 > Leu IMI +SU
ALS -TATA 2. Ala 122 > Thr IMI +SU
pALS-TATA 3. Pro 197 > Ser IMI +SU
ALS -TATA 4. Ala 122 > Thr and Pro 197 > Ser IMI +SU
pALS-TATA 5. Ala 122 > Thr and Trp 574 > Leu IMI +SU
pALS-TATA 6. Pro 197 > Ser and Trp 574 > Leu IMI +SU
ALS -TATA 7. Ala 122 > Thr and Pro 197 > Ser and Trp 574 > Leu IMI +SU
35S Trp 574 > Leu IMI +SU
In the transformation procedure we used a PC0300 plant transformation vector.
We have removed all needless DNA sequences from T-DNA of the vector. Therefore, only some nucleotides from bacterial T-DNA borders are left. Moreover, no antibiotic resistance genes were used in transformation. As a result, only plant natural ALS sequences containing engineered point-mutations are transferred into the plant.
EXAMPLE 1. DNA cloning Figure 1 illustrates the scheme of cloning plant transformation vectors containing ALS gene according to this disclosure.
9 Multiple cloning sites (containing several restriction sites) for further cloning of acetolactate synthase gene (ALS-MCS) was cloned by amplifying fragment formed by phosphorylated primers ALS-MCS-F
(SEQ ID NO:1) and ALS-MCS-R (SEQ ID NO:2) and cloning it into XmnI-Pmel digested dephosphorylated pC0300 to make pC0300-ALS-MCS vector carrying the multiple cloning site as is shown in Fig. 2.
253 5 bp up-stream region of A. t. ALS 1 gene, putatively containing promoter of ALS 1 gene, was amplified in PCR using primers P-At-ALS-F1 (SEQ ID NO: 3) and P-At-ALS-R1 (SEQ
ID NO: 4).
Another 2069 bp fragment, putatively containing A. t. ALS 1 gene CDS, was amplified in PCR using primers At-ALS-Fl (SEQ ID NO: 5) and At-ALS-RI (SEQ ID NO: 6). The third, 2434 bp fragment, putatively containing A.t. ALS1 3'UTR, was amplified in PCR using primers T-At-ALS-F1 (SEQ ID
NO:7) and T-At-ALS-R1 (SEQ ID NO:8) . Genomic DNA of A. t. Col-0 was used as a template in PCR using Fusion Polymerase (Finnzymes) in reaction conditions according to manufacturer's recommendations. Fig. 3 illustrates cloning of Arabidopsis thaliana (A.t) ALS1-gene and regions up-and down-stream from the gene.
PCR-product, which was obtained by using primers P-At-ALS-F1 (SEQ ID NO: 3) and P-At-ALS-R1 (SEQ ID NO:4) was precipitated and digested with Xbal and Ncol restriction enzymes and cloned into plant transformation vector pC0300-ALS-MCS, which was opened by using the same restriction enzymes and the vector was dephosphorylated. The new clone was named as pC0300-P-At-ALS.
Figure 4 illustrates cloning of pC0300-P-At-ALS containing ALS promoter region of Arabidopsis thaliana (SEQ ID NO: 9) The PCR-product, was obtained by using primers T-At-ALS-F1 (SEQ ID NO:7) and T-At-ALS-R1 (SEQ ID NO:8), and putatively was precipitated and digested with Agel and MfeI
restriction enzymes, and cloned into plant transformation vector pC0300-P-At-ALS. MCS, which was opened by using AarI
and MfeI restriction enzymes and dephosphorylated. The new clone was named pC0300-PT-At-ALS.
Figure 5 illustrates cloning of pC0300-PT-At-ALS construct containing promoter region (R)(SEQ ID
NO:9) and transcription termination region (T) ( SEQ ID NO: 10) of ALS gene.
The PCR-product, which was obtained by using primers T-At-ALS-F 1 (SEQ ID NO:
7) and T-At-ALS-R1 9 ( SEQ ID NO:8) was precipitated and digested with Agel and MfeI
restriction enzymes, and cloned into plant transformation vector pC0300-ALS-MCS, which was opened by using AarI and MfeI
restriction enzymes and dephosphorylated. The new clone was named pC0300-T-At-ALS. Figure 6 illustrates cloning of pC0300-T-At-ALS.
P35S was cut from pC1301 by using EcoRI and NcoI restriction enzymes and cloned into pC0300-T-At-ALS, which was opened with the same enzymes and dephosphorylated. Figure 7 illustrates cloning of pC0300-P35S T-At-ALS plant transformation vector containing 35S promoter of Cauliflower Mosaic Virus (SEQ ID NO: 11) and Transcription termination region of the ALS
gene of Arabidopsis thaliana (SEQ ID NO: 10).
Figure 8 illustrates cloning of pVKI-At-ALS containing coding region of ALS
gene amplified in PCR
on genomic DNA of Arabidopsis thaliana. A. t. ALS 1 gene was amplified from A.
t. genomic DNA by using primers At-ALS-F1 (SEQ ID NO: 5) and At-ALs-Ri (SEQ ID NO: 6). The 2069 bp product was cut by using NcoI and Agel restriction enzymes, gel-purified and cloned into pVKI vector, which was cut with Ncol and Agel restriction enzymes dephosphorylated and gel-purified.
The construct was named pVKI-At-ALS.
mRNA of Arabidopsis thaliana (the source plant for ALS gene) and Camelina sativa ALS genes are very close to each other by their sequence, which brings the problem of how to detect foreign mutated gene in transgenic plant. In order to be able to specifically detect transgenic ALS 1 transcripts by e.g.
using Northern hybridization or PCR-based methods, 103 bp piece of ALS 3'UTR
of Papaver rhoeas (SEQ ID NO: 14), (which had clear sequence difference with A. t. ALS 1 3'UTR) was cloned into Agel-site close after A. t. ALS 1 gene's STOP codon. The Papaver rhoeas ALS 3'UTR-fragment was cloned by amplifying two overlapping oligonucleotides, Pr3'-F (SEQ ID NO: 12) and Pr3'-R (SEQ ID NO:
13). The product had one nucleotide error comparing to the origin sequence, which was not repaired.
The oligonucleotides carried sites for Eco3 11, outside cutting restriction enzyme. After cutting with Eco3lI and cloning into pVKI-At-ALS Agel-site, the 5'-site was removed and 3'-site restored for Agel restriction enzyme. The construct was named pVKI-At-ALS-Pr3'. Figure 9 illustrates cloning of Papaver rhoeas ALS 3'UTR downstream ofA.t. ALS1-gene in pVKI cloning vector.
Mutagenesis was conducted by using PCR and primers carrying the mutating nucleotides. A122T
mutation was conducted by amplifying two pieces of A. t. ALS 1 gene. Primers M13F (SEQ ID NO: 15) and ALS-A122T-R (SEQ ID NO: 16) were used to amplify the 5' of the mutagenized fragment, and ALS-A122T-F (SEQ ID NO: 17) and ALS-MluI-R (SEQ ID NO: 18) the 3'-part of the fragment. The alanine to threonine mutation was in the middle of ALS-A122T-F (SEQ ID NO: 17) and ALS-A122T-R (SEQ ID NO: 16) primers, which were complementary to each other. PCR was conducted by using NcoI-linearized pVKI-At-ALS-Pr3' as a template by using high fidelity Phusion polymerase (Finnzymes) according to manufacturer's recommendations. After gel-purification, the fragments were used as templates in secondary PCR by using primers M13-F (SEQ ID NO: 15) and ALS-MluI-R
(SEQ ID NO: 18), and the complementary ends of the fragments. The product carried Ncol and Mlu!
restriction sites, which were used to clone the mutagenized fragment into pVKI-At-ALS-Pr3' to make pVKI-At-ALS-A122T as shown in Figure 10.
P197S mutation was created by amplifying a piece ofA.t. ALSI gene. Primers M13F (SEQ ID NO: 15) and ALS-P197S-R (SEQ ID NO:19) were used to amplify the mutagenized fragment.
The proline to serine mutation was in the middle of P197S-R primer. PCR was conducted by using NcoI-linearized pVKI-At-ALS-Pr3' as template by using high fidelity Phusion polymerase (Finnzymes) according to the manufacturer's recommendations. The product carried NcoI and Mlul restriction sites, which were used to clone the mutagenized fragment into pVK I -At-ALS-Pr3' to make pVKI-At-ALS-P197S.
W574L mutation was created by amplifying two pieces of A.t. ALS1 gene. Primers ALS-NheI-F (SEQ
ID NO: 20) and ALS-W574L-R (SEQ ID NO: 21) were used to amplify the 5' of the mutagenized fragment and ALS-W574L-F (SEQ ID NO:22) and M13-R (SEQ ID NO:23) the 3'-partof the fragment. The tryptophan to leucine mutation was in the middle of ALS-W574L-F
(SEQ ID NO: 22) and W574L-R (SEQ ID NO: 21) primers, which were complementary to each other.
The fragments were used as templates after gel-purification in secondary PCR using primers ALS-NheI-F (SEQ ID
NO: 20), M13-R (SEQ ID NO: 23), and the complementary ends of the fragments.
The product carried NheI and Age! restriction sites, which were used to clone to clone the mutagenized fragment into pVKI-At-ALS-Pr3' to make pVKI-At-ALS-W574L.
In addition to single mutations, we also created double and triple mutations in the A.t. ALS gene.
A122T, P197S -double mutation was created by swapping the region between Eco8ll and Mlul from pVKI-ALS-P197S to pVKI-At-A122T to make pVKI-AtALS-A122T-P197S. A122T, 574L -double mutation was created by swapping the region between Xbal and Nhel -sites from pVKI-At-A122T to VK1-At-ALS-W574L to make pVKI-At-ALS-A122T-W574L. P197S, W5474L -double mutation was created by swapping the region between Xbal and NheI -sites from pVK1-At-ALS-P197S to pVK1-At-ALS-W574L to make pVKI-P197S-W574L.
The mutation carrying all three mutations was created by swapping the region between NheI and XbaI
-sites from pVK1-At-ALS-A122T-P197S to pVKI-At-ALS-W574L to make pVKI-At-ALS-P197S-W574L.
Figure 11 illustrates cloning of mutated ALS 1 gene into plant transformation vectors. All versions of mutated ALS1 gene were cut out from pVKI vector by using restriction enzymes Ncol and Agel, and cloned into pC0300-PT-At-ALS plant vector, which was digested by using Ncol and Aarl restriction enzymes and dephosphorylated. As an example it is shown construction of pC0300-PT-At-ALS-A122T-P197S-W574L.
A. t. ALS 1 5'UTR contains SEC61 gene (SEQ ID NO:25) close upstream of ALS 1 CDS (SEQ ID
NO:24). In order to prevent extra transcription from the transgene, WebGene HCTATA was used to predict the TATA-boxes of SEC61 gene. Figure 12 illustrates the mutation (removal) of SEC61 putative TATA-boxes. Resulting mutated P-At-ALS sequence is according to SEQ
ID NO:33.
P-At-ALS-SacI-F (SEQ ID NO: 26) and mTATA-R (SEQ ID NO: 27) were used to amplify the 5'-fragment of the TATA-region, mTATA-F (SEQ ID NO:28) and mTATA-R (SEQ ID NO:29) the middle-part of the region and mTATA-F (SEQ ID NO:30) and At-ALS-PvuI-R (SEQ ID
NO:3 1) the 3'-part of the region. After gel purification, the parts were used as templates to combine the region by using P-At-ALS.SacI-F (SEQ ID NO:26) and At-ALS-PvuI-R (SEQ ID NO:31) as primers. The product was cut with Sac! and Pvul restriction enzymes, gel-purified and cloned into pC0300-PT-At-ALS to make pm2T. All seven mutated A. t. ALS 1 forms were cloned into pm2T, which were digested by using Ncol and Aarl restriction enzymes and dephosphorylated, similarly as shown in Figure 11.
EXAMPLE 2. Plant transformation The seeds of Camelina sativa plant grown in greenhouse were sterilized by immersing in 70% ethanol for 1 min and then treating for 5 minutes in 2.5% active Cl (Na-hypoclorite) with an addition of Tween-20 (I drop per 100 ml). After sterilization the seeds were washed three times in sterile water and placed on solid Murashige and Skoog (MS) agar medium (Murashige and Skoog, Physiol. Plant.
15:472-493, 1962) without sugars for germination. Sterilized seeds were germinated and grown 10 days on solid MS- medium without hormones. Green leaves served as a source of explants for transformation procedure.
Agrobacterium tumefaciens strain c58 carrying plasmid pC0300 containing various ALS gene mutation as described above, was grown overnight at 28 C with shaking in liquid YEB
medium (Lichtenstein and Draper, Gene Engineering of Plants. In: Glover D M (ed.) DNA Cloning--A
Practical Approach, vol. 2. Oxford IRL, Oxford, pp 67-119, 1985) supplemented with 50 mg/l kanamycin and 12.5 mg/1 rifampicin. Subsequently an aliquot of the culture ({fraction (1/100)1 v/v) was inoculated in fresh YEB
medium supplemented with 50 mg/l kanamycin and 12.5 mg/l rifampicin and the bacteria were grown overnight with shaking. Agrobacterium culture of OD600=1.0 was used in the transformation experiments.
The first true leaves of in vitro grown Camelina sativa plants cv. Calena, Celine, and Blane Creek were cut across the leaf blade. The explants were immersed for 1-3 min in MS
solution inoculated with a dilution (e.g. 1/10 v/v) of the overnight culture of Agrobacterium tumefaciens. Redundant liquid on the leaf segments was removed with filter paper and the leaf segments were cultivated for 48 hours on MS
0.7% agar medium supplemented with 0.7-1.5 mg/16-benzylaminopurine (BAP) and 0.3-1.0 mg/l alpha-naphthaleneacetic acid (NAA). All the MS culture medias were supplemented with 2% sucrose and all in vitro cultures were kept at temperatures of 25 C (day) and 18 C
(night) with a photoperiod of 16 h.
After the co-cultivation, the explants were washed with water containing Ticarcillin (Duchefa) 200 mg /1. The surfaces of the explants were dried on filter paper and the explants were placed on MS medium supplemented with hormones 0.7-1.5 mg/l 6-benzylaminopurine (BAP), 0.3-1.0 mg/l alpha-naphthaleneacetic acid (NAA) and 100 mg/l Ticarcillin.
After 7-10 days leaf explants were transferred to new MS medium containing 0.7-1.5 mg/l BAP 2-3%
sucrose and 150-200 mg/l Ticarcillin for shoot regeneration.
Shoots developed in 7 to 14 days were cut, grown on the same media and rooted in presence of auxines.
The rooted plants were transferred into soil in greenhouse.
EXAMPLE 3. Resistance to herbicides and selection of transgenic shoots Because various mutations of ALS gene confer different resistance to plants, we used herbicide imidazolinon: Imazamox (IMI) and two types of sulfonylurea (SU): Metsulfuron-methyl (MSU) and Chlorsulfuron (CSU) (Sigma). It is known that mutation A122 confers resistance to IMI, P197 to SU, and W574 to both IMI and SU.
We did not use antibiotic selection in plant transformation. We have shown before (E.G. US patent application 12/290,379) that there is no need for selection when Camelina plants are transformed as described here and in above publication, because the transformation rate is so high. However in the case of herbicide resistance, as described here, the herbicide can also be used as selection factor.
Figure 13 shows one of such in vitro leaf segment test of two transgenic C.
sativa cv. Celine lines VK6-Al-No24 and VK6-Al-No26 transformed with Al construct (35S promoter - ALS
W574 mutant - 35S terminator). As controls, we used leaf segments of herbicide resistant natural ALS mutant of Camelina microcarpa that has broad resistance to class-2 herbicides and leaf segments of susceptible Camelina sativa. From the figure it can be clearly seen that leaf segments of transgenic plants are resistant to the herbicides, while non-transgenic Camelina sativa is susceptible.
From this and other tests, it was clear that concentrations of 0.1 mg/1 IMI
(A122 and W574 mutants) and 0.01 mg/1(P 197 mutant) were appropriate for testing of transgenic shoots.
Figure 14 shows IMI
and MSU 10 day-tests applied to the shoots recovered after transformation of Blane Creek. Green and well-developed shoots are most evidently transgenic with good expression of the mutant ALS gene.
Such shoots were transferred to fresh MS agar with the same herbicides to prove the resistance of the shoots.
The herbicide resistance test can also be performed by using surface sterilized seeds that are germinated on the herbicide containing media similar way than leaf explants are grown. Growth of the seedlings is then followed and effects of variable herbicide concentrations are monitored, as it is shown in Figure 16 and Table 3.
We have also developed selection of transgenic tissues with the herbicides during callus formation.
Camelina sativa leaf explants 3-5 days after co-cultivation were exposed to 0.01-0.02 mg/l IMI for 3-5 days. After that the explants were returned to the same callus regeneration MS
agar (0.7-1.5 mg/l BAP
and 0.3-1.0 mg/l NAA). Transfer to shoot regeneration media after selection was delayed for 4-6 days.
However, the majority of recovered shoots were transgenic (average 60-70% and achieving 105%
transgenic shoots per transformed explants). The total number of transformed shoots also increased by 5-10 fold as compared to selection-free method.
EXAMPLE 3. Molecular analysis of transgenic expression PCR Analysis Total genomic DNA was isolated from leaf tissue of transgenic and non-transgenic Camelina sativa plants by using DNeasy Plant Mini Kit according to the supplier's instructions (Qiagen). The presence of the ALS gene in the herbicide resistant plants was determined by PCR
analysis by using 24 nucleotides long primers specific to the promoter sequences of ALS and hpt genes. PCR reaction mix contained approximately 1 ng/ l of template DNA and DyNAzyme polymerase (Finnzymes) was used for amplification. PCR program consisted of. 94 C for 2 min; 30 cycles of 94 C. for 30 sec, 48 C for 30 sec and 72 C for 2 min. Three micro liters of PCR reaction mixture was run at 100 V in 0.8%
agarose gel containing ethidium bromide. No PCR product was obtained when non-transgenic Camelina sativa DNA was used as template, whereas when using transgenic Camelina sativa an amplification product of 700 nucleotides corresponding to the positive control was obtained, which confirmed the presence of transgene in these Camelina sativa plants.
RT-PCR assay of the RNA expression and in the herbicide resistant plants Plant total RNA was isolated from approximately 20 mg leaf samples by using E.Z.N.A Plant RNA kit (Omega Bio-Tek). 250 ng of each sample were denatured in Glyoxal/DMSO RNA
loading buffer (Ambion) containing SYBR nucleic acid stain (Molecular Probes). 1 g of each RNA sample was reverse transcribed with RevertAid RNaseH- M-MLV reverse transcriptase 200 u (Fermentas) in 25 l reactions consisting in addition to the enzymes, own 1 X buffer, 1 mM dNTPs, 2 M random nonamer primers (Sigma-Aldrich), 1.5 pl D(+) trehalose (saturated at room temperature), 800 mM D(+) sorbitol,
(SEQ ID NO:1) and ALS-MCS-R (SEQ ID NO:2) and cloning it into XmnI-Pmel digested dephosphorylated pC0300 to make pC0300-ALS-MCS vector carrying the multiple cloning site as is shown in Fig. 2.
253 5 bp up-stream region of A. t. ALS 1 gene, putatively containing promoter of ALS 1 gene, was amplified in PCR using primers P-At-ALS-F1 (SEQ ID NO: 3) and P-At-ALS-R1 (SEQ
ID NO: 4).
Another 2069 bp fragment, putatively containing A. t. ALS 1 gene CDS, was amplified in PCR using primers At-ALS-Fl (SEQ ID NO: 5) and At-ALS-RI (SEQ ID NO: 6). The third, 2434 bp fragment, putatively containing A.t. ALS1 3'UTR, was amplified in PCR using primers T-At-ALS-F1 (SEQ ID
NO:7) and T-At-ALS-R1 (SEQ ID NO:8) . Genomic DNA of A. t. Col-0 was used as a template in PCR using Fusion Polymerase (Finnzymes) in reaction conditions according to manufacturer's recommendations. Fig. 3 illustrates cloning of Arabidopsis thaliana (A.t) ALS1-gene and regions up-and down-stream from the gene.
PCR-product, which was obtained by using primers P-At-ALS-F1 (SEQ ID NO: 3) and P-At-ALS-R1 (SEQ ID NO:4) was precipitated and digested with Xbal and Ncol restriction enzymes and cloned into plant transformation vector pC0300-ALS-MCS, which was opened by using the same restriction enzymes and the vector was dephosphorylated. The new clone was named as pC0300-P-At-ALS.
Figure 4 illustrates cloning of pC0300-P-At-ALS containing ALS promoter region of Arabidopsis thaliana (SEQ ID NO: 9) The PCR-product, was obtained by using primers T-At-ALS-F1 (SEQ ID NO:7) and T-At-ALS-R1 (SEQ ID NO:8), and putatively was precipitated and digested with Agel and MfeI
restriction enzymes, and cloned into plant transformation vector pC0300-P-At-ALS. MCS, which was opened by using AarI
and MfeI restriction enzymes and dephosphorylated. The new clone was named pC0300-PT-At-ALS.
Figure 5 illustrates cloning of pC0300-PT-At-ALS construct containing promoter region (R)(SEQ ID
NO:9) and transcription termination region (T) ( SEQ ID NO: 10) of ALS gene.
The PCR-product, which was obtained by using primers T-At-ALS-F 1 (SEQ ID NO:
7) and T-At-ALS-R1 9 ( SEQ ID NO:8) was precipitated and digested with Agel and MfeI
restriction enzymes, and cloned into plant transformation vector pC0300-ALS-MCS, which was opened by using AarI and MfeI
restriction enzymes and dephosphorylated. The new clone was named pC0300-T-At-ALS. Figure 6 illustrates cloning of pC0300-T-At-ALS.
P35S was cut from pC1301 by using EcoRI and NcoI restriction enzymes and cloned into pC0300-T-At-ALS, which was opened with the same enzymes and dephosphorylated. Figure 7 illustrates cloning of pC0300-P35S T-At-ALS plant transformation vector containing 35S promoter of Cauliflower Mosaic Virus (SEQ ID NO: 11) and Transcription termination region of the ALS
gene of Arabidopsis thaliana (SEQ ID NO: 10).
Figure 8 illustrates cloning of pVKI-At-ALS containing coding region of ALS
gene amplified in PCR
on genomic DNA of Arabidopsis thaliana. A. t. ALS 1 gene was amplified from A.
t. genomic DNA by using primers At-ALS-F1 (SEQ ID NO: 5) and At-ALs-Ri (SEQ ID NO: 6). The 2069 bp product was cut by using NcoI and Agel restriction enzymes, gel-purified and cloned into pVKI vector, which was cut with Ncol and Agel restriction enzymes dephosphorylated and gel-purified.
The construct was named pVKI-At-ALS.
mRNA of Arabidopsis thaliana (the source plant for ALS gene) and Camelina sativa ALS genes are very close to each other by their sequence, which brings the problem of how to detect foreign mutated gene in transgenic plant. In order to be able to specifically detect transgenic ALS 1 transcripts by e.g.
using Northern hybridization or PCR-based methods, 103 bp piece of ALS 3'UTR
of Papaver rhoeas (SEQ ID NO: 14), (which had clear sequence difference with A. t. ALS 1 3'UTR) was cloned into Agel-site close after A. t. ALS 1 gene's STOP codon. The Papaver rhoeas ALS 3'UTR-fragment was cloned by amplifying two overlapping oligonucleotides, Pr3'-F (SEQ ID NO: 12) and Pr3'-R (SEQ ID NO:
13). The product had one nucleotide error comparing to the origin sequence, which was not repaired.
The oligonucleotides carried sites for Eco3 11, outside cutting restriction enzyme. After cutting with Eco3lI and cloning into pVKI-At-ALS Agel-site, the 5'-site was removed and 3'-site restored for Agel restriction enzyme. The construct was named pVKI-At-ALS-Pr3'. Figure 9 illustrates cloning of Papaver rhoeas ALS 3'UTR downstream ofA.t. ALS1-gene in pVKI cloning vector.
Mutagenesis was conducted by using PCR and primers carrying the mutating nucleotides. A122T
mutation was conducted by amplifying two pieces of A. t. ALS 1 gene. Primers M13F (SEQ ID NO: 15) and ALS-A122T-R (SEQ ID NO: 16) were used to amplify the 5' of the mutagenized fragment, and ALS-A122T-F (SEQ ID NO: 17) and ALS-MluI-R (SEQ ID NO: 18) the 3'-part of the fragment. The alanine to threonine mutation was in the middle of ALS-A122T-F (SEQ ID NO: 17) and ALS-A122T-R (SEQ ID NO: 16) primers, which were complementary to each other. PCR was conducted by using NcoI-linearized pVKI-At-ALS-Pr3' as a template by using high fidelity Phusion polymerase (Finnzymes) according to manufacturer's recommendations. After gel-purification, the fragments were used as templates in secondary PCR by using primers M13-F (SEQ ID NO: 15) and ALS-MluI-R
(SEQ ID NO: 18), and the complementary ends of the fragments. The product carried Ncol and Mlu!
restriction sites, which were used to clone the mutagenized fragment into pVKI-At-ALS-Pr3' to make pVKI-At-ALS-A122T as shown in Figure 10.
P197S mutation was created by amplifying a piece ofA.t. ALSI gene. Primers M13F (SEQ ID NO: 15) and ALS-P197S-R (SEQ ID NO:19) were used to amplify the mutagenized fragment.
The proline to serine mutation was in the middle of P197S-R primer. PCR was conducted by using NcoI-linearized pVKI-At-ALS-Pr3' as template by using high fidelity Phusion polymerase (Finnzymes) according to the manufacturer's recommendations. The product carried NcoI and Mlul restriction sites, which were used to clone the mutagenized fragment into pVK I -At-ALS-Pr3' to make pVKI-At-ALS-P197S.
W574L mutation was created by amplifying two pieces of A.t. ALS1 gene. Primers ALS-NheI-F (SEQ
ID NO: 20) and ALS-W574L-R (SEQ ID NO: 21) were used to amplify the 5' of the mutagenized fragment and ALS-W574L-F (SEQ ID NO:22) and M13-R (SEQ ID NO:23) the 3'-partof the fragment. The tryptophan to leucine mutation was in the middle of ALS-W574L-F
(SEQ ID NO: 22) and W574L-R (SEQ ID NO: 21) primers, which were complementary to each other.
The fragments were used as templates after gel-purification in secondary PCR using primers ALS-NheI-F (SEQ ID
NO: 20), M13-R (SEQ ID NO: 23), and the complementary ends of the fragments.
The product carried NheI and Age! restriction sites, which were used to clone to clone the mutagenized fragment into pVKI-At-ALS-Pr3' to make pVKI-At-ALS-W574L.
In addition to single mutations, we also created double and triple mutations in the A.t. ALS gene.
A122T, P197S -double mutation was created by swapping the region between Eco8ll and Mlul from pVKI-ALS-P197S to pVKI-At-A122T to make pVKI-AtALS-A122T-P197S. A122T, 574L -double mutation was created by swapping the region between Xbal and Nhel -sites from pVKI-At-A122T to VK1-At-ALS-W574L to make pVKI-At-ALS-A122T-W574L. P197S, W5474L -double mutation was created by swapping the region between Xbal and NheI -sites from pVK1-At-ALS-P197S to pVK1-At-ALS-W574L to make pVKI-P197S-W574L.
The mutation carrying all three mutations was created by swapping the region between NheI and XbaI
-sites from pVK1-At-ALS-A122T-P197S to pVKI-At-ALS-W574L to make pVKI-At-ALS-P197S-W574L.
Figure 11 illustrates cloning of mutated ALS 1 gene into plant transformation vectors. All versions of mutated ALS1 gene were cut out from pVKI vector by using restriction enzymes Ncol and Agel, and cloned into pC0300-PT-At-ALS plant vector, which was digested by using Ncol and Aarl restriction enzymes and dephosphorylated. As an example it is shown construction of pC0300-PT-At-ALS-A122T-P197S-W574L.
A. t. ALS 1 5'UTR contains SEC61 gene (SEQ ID NO:25) close upstream of ALS 1 CDS (SEQ ID
NO:24). In order to prevent extra transcription from the transgene, WebGene HCTATA was used to predict the TATA-boxes of SEC61 gene. Figure 12 illustrates the mutation (removal) of SEC61 putative TATA-boxes. Resulting mutated P-At-ALS sequence is according to SEQ
ID NO:33.
P-At-ALS-SacI-F (SEQ ID NO: 26) and mTATA-R (SEQ ID NO: 27) were used to amplify the 5'-fragment of the TATA-region, mTATA-F (SEQ ID NO:28) and mTATA-R (SEQ ID NO:29) the middle-part of the region and mTATA-F (SEQ ID NO:30) and At-ALS-PvuI-R (SEQ ID
NO:3 1) the 3'-part of the region. After gel purification, the parts were used as templates to combine the region by using P-At-ALS.SacI-F (SEQ ID NO:26) and At-ALS-PvuI-R (SEQ ID NO:31) as primers. The product was cut with Sac! and Pvul restriction enzymes, gel-purified and cloned into pC0300-PT-At-ALS to make pm2T. All seven mutated A. t. ALS 1 forms were cloned into pm2T, which were digested by using Ncol and Aarl restriction enzymes and dephosphorylated, similarly as shown in Figure 11.
EXAMPLE 2. Plant transformation The seeds of Camelina sativa plant grown in greenhouse were sterilized by immersing in 70% ethanol for 1 min and then treating for 5 minutes in 2.5% active Cl (Na-hypoclorite) with an addition of Tween-20 (I drop per 100 ml). After sterilization the seeds were washed three times in sterile water and placed on solid Murashige and Skoog (MS) agar medium (Murashige and Skoog, Physiol. Plant.
15:472-493, 1962) without sugars for germination. Sterilized seeds were germinated and grown 10 days on solid MS- medium without hormones. Green leaves served as a source of explants for transformation procedure.
Agrobacterium tumefaciens strain c58 carrying plasmid pC0300 containing various ALS gene mutation as described above, was grown overnight at 28 C with shaking in liquid YEB
medium (Lichtenstein and Draper, Gene Engineering of Plants. In: Glover D M (ed.) DNA Cloning--A
Practical Approach, vol. 2. Oxford IRL, Oxford, pp 67-119, 1985) supplemented with 50 mg/l kanamycin and 12.5 mg/1 rifampicin. Subsequently an aliquot of the culture ({fraction (1/100)1 v/v) was inoculated in fresh YEB
medium supplemented with 50 mg/l kanamycin and 12.5 mg/l rifampicin and the bacteria were grown overnight with shaking. Agrobacterium culture of OD600=1.0 was used in the transformation experiments.
The first true leaves of in vitro grown Camelina sativa plants cv. Calena, Celine, and Blane Creek were cut across the leaf blade. The explants were immersed for 1-3 min in MS
solution inoculated with a dilution (e.g. 1/10 v/v) of the overnight culture of Agrobacterium tumefaciens. Redundant liquid on the leaf segments was removed with filter paper and the leaf segments were cultivated for 48 hours on MS
0.7% agar medium supplemented with 0.7-1.5 mg/16-benzylaminopurine (BAP) and 0.3-1.0 mg/l alpha-naphthaleneacetic acid (NAA). All the MS culture medias were supplemented with 2% sucrose and all in vitro cultures were kept at temperatures of 25 C (day) and 18 C
(night) with a photoperiod of 16 h.
After the co-cultivation, the explants were washed with water containing Ticarcillin (Duchefa) 200 mg /1. The surfaces of the explants were dried on filter paper and the explants were placed on MS medium supplemented with hormones 0.7-1.5 mg/l 6-benzylaminopurine (BAP), 0.3-1.0 mg/l alpha-naphthaleneacetic acid (NAA) and 100 mg/l Ticarcillin.
After 7-10 days leaf explants were transferred to new MS medium containing 0.7-1.5 mg/l BAP 2-3%
sucrose and 150-200 mg/l Ticarcillin for shoot regeneration.
Shoots developed in 7 to 14 days were cut, grown on the same media and rooted in presence of auxines.
The rooted plants were transferred into soil in greenhouse.
EXAMPLE 3. Resistance to herbicides and selection of transgenic shoots Because various mutations of ALS gene confer different resistance to plants, we used herbicide imidazolinon: Imazamox (IMI) and two types of sulfonylurea (SU): Metsulfuron-methyl (MSU) and Chlorsulfuron (CSU) (Sigma). It is known that mutation A122 confers resistance to IMI, P197 to SU, and W574 to both IMI and SU.
We did not use antibiotic selection in plant transformation. We have shown before (E.G. US patent application 12/290,379) that there is no need for selection when Camelina plants are transformed as described here and in above publication, because the transformation rate is so high. However in the case of herbicide resistance, as described here, the herbicide can also be used as selection factor.
Figure 13 shows one of such in vitro leaf segment test of two transgenic C.
sativa cv. Celine lines VK6-Al-No24 and VK6-Al-No26 transformed with Al construct (35S promoter - ALS
W574 mutant - 35S terminator). As controls, we used leaf segments of herbicide resistant natural ALS mutant of Camelina microcarpa that has broad resistance to class-2 herbicides and leaf segments of susceptible Camelina sativa. From the figure it can be clearly seen that leaf segments of transgenic plants are resistant to the herbicides, while non-transgenic Camelina sativa is susceptible.
From this and other tests, it was clear that concentrations of 0.1 mg/1 IMI
(A122 and W574 mutants) and 0.01 mg/1(P 197 mutant) were appropriate for testing of transgenic shoots.
Figure 14 shows IMI
and MSU 10 day-tests applied to the shoots recovered after transformation of Blane Creek. Green and well-developed shoots are most evidently transgenic with good expression of the mutant ALS gene.
Such shoots were transferred to fresh MS agar with the same herbicides to prove the resistance of the shoots.
The herbicide resistance test can also be performed by using surface sterilized seeds that are germinated on the herbicide containing media similar way than leaf explants are grown. Growth of the seedlings is then followed and effects of variable herbicide concentrations are monitored, as it is shown in Figure 16 and Table 3.
We have also developed selection of transgenic tissues with the herbicides during callus formation.
Camelina sativa leaf explants 3-5 days after co-cultivation were exposed to 0.01-0.02 mg/l IMI for 3-5 days. After that the explants were returned to the same callus regeneration MS
agar (0.7-1.5 mg/l BAP
and 0.3-1.0 mg/l NAA). Transfer to shoot regeneration media after selection was delayed for 4-6 days.
However, the majority of recovered shoots were transgenic (average 60-70% and achieving 105%
transgenic shoots per transformed explants). The total number of transformed shoots also increased by 5-10 fold as compared to selection-free method.
EXAMPLE 3. Molecular analysis of transgenic expression PCR Analysis Total genomic DNA was isolated from leaf tissue of transgenic and non-transgenic Camelina sativa plants by using DNeasy Plant Mini Kit according to the supplier's instructions (Qiagen). The presence of the ALS gene in the herbicide resistant plants was determined by PCR
analysis by using 24 nucleotides long primers specific to the promoter sequences of ALS and hpt genes. PCR reaction mix contained approximately 1 ng/ l of template DNA and DyNAzyme polymerase (Finnzymes) was used for amplification. PCR program consisted of. 94 C for 2 min; 30 cycles of 94 C. for 30 sec, 48 C for 30 sec and 72 C for 2 min. Three micro liters of PCR reaction mixture was run at 100 V in 0.8%
agarose gel containing ethidium bromide. No PCR product was obtained when non-transgenic Camelina sativa DNA was used as template, whereas when using transgenic Camelina sativa an amplification product of 700 nucleotides corresponding to the positive control was obtained, which confirmed the presence of transgene in these Camelina sativa plants.
RT-PCR assay of the RNA expression and in the herbicide resistant plants Plant total RNA was isolated from approximately 20 mg leaf samples by using E.Z.N.A Plant RNA kit (Omega Bio-Tek). 250 ng of each sample were denatured in Glyoxal/DMSO RNA
loading buffer (Ambion) containing SYBR nucleic acid stain (Molecular Probes). 1 g of each RNA sample was reverse transcribed with RevertAid RNaseH- M-MLV reverse transcriptase 200 u (Fermentas) in 25 l reactions consisting in addition to the enzymes, own 1 X buffer, 1 mM dNTPs, 2 M random nonamer primers (Sigma-Aldrich), 1.5 pl D(+) trehalose (saturated at room temperature), 800 mM D(+) sorbitol,
10 u SUPERase-in RNase inhibitor (Ambion). Samples were incubated 25 C, 5 min; 37 C, 5 min; 42 C, 5 min; 55 C, 5 min; 93 C, 3 min.
2 l of each RT-reactions was used as template in 20 pl PCR reactions using Dynazyme II polymerase 1 u (Finnzymes) in it's own 1X buffer 100 M dNTPs (-the same amount comes with the template from RT-reactions) 2% DMSO, GUS-5'-F and 250 nM GUS-e2-R primers. Program: 95 C 4 min., 35 X [(95 C, 30 s), (52 C, 20 s), (72 C, 30 s)].
The primers for RT-PCR were designed to match the 103 nucleotide sequence (SEQ
ID NO:14) from transcription terminator region of ALS gene of Papaver rhoeas (which was introduced close downstream of stop codon the mutated Arabidopsis ALS gene specifically for this purpose). Most of the RNA samples produced the right size amplification product confirming the right mRNA expression of foreign ALS gene.
Southern Analysis Total genomic DNA was isolated from leaf tissue of Camelina sativa plants by CTAB extraction and DEAE sepharose purification. Leaf material of 10 transgenic ALS plant lines of cv. Blane Creek of third generation was joined and used for DNA isolation. Southern Analysis was conducted of the samples of transgenic ALS plant lines of third generation:
ALS1.2 (VK12A8.18) ALS2.2 (KK21A14.1.2) ALS3.3 (KK21A14.3) ALS5.1 (VK13A14.1) ALS7.3 (KK24A14.4) ALS8.3 (KK18A8/KK2OA7) ALS9.1 (KK18A8/KK20A7) ALS10.3 (VK12A8.9.1) ALS11.3 (VK10A5.3) ALS22.3 (VK13A15.12) Eight micrograms of total DNA of Camelina sativa plants was digested with Xbal restriction enzyme.
These enzyme cut out 5.8 kb fragment of almost whole T-DNA region. Digested DNA samples were separated in a 0.8% agarose gel in overnight electrophoresis at 9 V and 15 mA
current and transferred to positively charged nylon membrane (Boehringer, Mannheim) using capillary transfer. RNA probes were synthesized using T7 RNA polymerase on the PCR product carrying promoter of Arabidopsis ALS gene and labeled with digoxigenin- 11 -UTP. The membrane was hybridized and developed according to the supplier's instructions (Boehringer, Mannheim, The DIG user's guide for filter hybridization): prehybridized at 50 C. for 2 h and hybridized at 50 C in a "DIG Easy Hyb"
hybridization solution (Boehringer, Mannheim) overnight with a digoxigenin-UTP
labeled RNA probe.
The concentration of RNA probe was 150 ng/ml. After hybridization the membrane was washed in SSC buffers, blocked and detected by using "Anti-Digoxigenin-AP alkaline phosphatase (Boehringer, Mannheim). Chemiluminescent detection was conducted with CSPD-substrate and the membrane was exposed to X-ray film. Presence of the transgene insertion was proved by comparison to DNA of non-transgenic Camelina sativa plant DNA as negative control (line BC + 1kb M), and to plasmid DNA
carrying the gene sequence, cut with restriction enzymes and mixed with non-transgenic plant DNA as positive control (line BC + M) (Fig. 15).
The Xbal cut 5.8 kb fragment contains whole ALS gene including promoter and part of terminator regions. Therefore the right size T-DNA insert should look as one 5.8 kb band in Fig. 15. If one recognition site of the Xbal restriction enzymes absence in the case of defective insert, the size of the detected band should differ 5.8 kb.
As a result of the Southern analysis we can say that all analyzed lines contain right size transgenic insert in the genome (Fig. 15). Plant lines of 1.2; 5.1; 7.3 and 10.3 (columns 1,4,5 and 8 in Fig. 15 respectively) do not contain defective inserts. Lines 2.2; 3.3; 8.3; 9.1; 11.3 and 22.3 (columns 2,3, 6,7,9 and 10 in Fig. 15, respectively) have extra bands caused by additional incomplete insert(s) in the genome.
EXAMPLE 4. Herbicide assays Seedlings of the developed transgenic lines of Camelina sativa, cultivars Blane Creek and Calena second (Ti) and fourth (T3) generations were exposed to various concentration of three herbicides:
imidazolinone (IMI), chlorsulfuron (CSU) and metsulfuron (MSU). Resistance of the transgenic lines was compared to control non-transgenic seedlings of C. sativa cv. Blane Creek.
Seeds were sterilized in 2% Na-hypocloride and placed on wet filter paper in sterile conditions to allow germination. On the next day well-germinated seedlings were transferred on Petri dishes containing MS (Murasige-Scoog) 0.7 % agar (without sucrose or hormones). Each dish contained one from the three herbicides in particular concentration (0.0001, 0.001, 0.01, 0.1, 1.0, 10, 100 mg/1). After one week of cultivation in vitro (+25 C/+18 C; light/dark) the seedlings were photographed (as shown on the figures 16A-16F). The highest survival concentration was found for each transgenic line and for each herbicide and compared to the non-transgenic control. The results are combined in the Table 3.
The results of the bioassay to herbicide resistance showed that:
1. Almost all transgenic lines bearing mutated ALS gene demonstrated increased herbicide resistance.
2. In the best lines resistance increased in 10 000 times as compared to non-transgenic control.
3. Each mutation has own spectrum of resistance. A - specifically increased resistance to IMI, P -to CSU, and W has a good resistance to IMI and CSU and it was less effective to MSU.
4. The best resistance reveals lines bearing double mutations PW: 1 000 - 10 000 increase in resistance to CSU and IMI, and 1 000 increase resistance to MSU.
5. Triple mutation (APW) plants also exhibit a good resistance to all three herbicides.
Table 3. Highest survival concentrations of herbicides for various transgenic lines of C. sativa.
Mutation Cultivar Line Generation Herbicide Highest Effect as surviving compared concentration to control mg/l No Blane Creek Wild type - IMI 0.01 1 No Blane Creek Wild type - CSU 0.001 1 No Blane Creek Wild type - MSU 0.001 1 A122T Calena A3 (VK9A3.4.1) Ti 10 1 000 Blane Creek A9.1 (VK14A9.1) Ti IMI 1.0 100 Slane Creek A9.2 (VK14A9.4.2) Ti 10 1 000 A122T Calena A3 (VK9A3.4.1) Ti 0.01 10 Blane Creek A9.1 (VK14A9.1) Ti CSU 0.001 1 Slane Creek A9.2 (VK14A9.4.2) Ti 0.01 10 A122T Calena A3 (VK9A3.4.1) Ti 0.01 10 Blane Creek A9.1 (VK14A9.1) Ti MSU 0.001 1 Slane Creek A9.2 VK14A9.4.2 Ti 0.001 1 P197S Calena A4 (VK9A4.4.2) Ti IMI 0.1 10 Slane Creek A10 VK14A10.16 Ti 0.1 10 P197S Calena A4 (VK9A4.4.2) Ti CSU 10 10 000 Slane Creek A10 VK14A10.16 Ti 1.0 1 000 P197S Calena A4 (VK9A4.4.2) Ti MSU 0.01 10 Slane Creek A10 VK14A10.16 Ti 0.01 10 W574L Blane Creek A2 (VKIOA2.2) T1 IMI 100 10 000 Blane Creek ALS23.3 T3 10 1 000 VKI OA2.3 W574L Blane Creek A2 (VKIOA2.2) Ti CSU 10 10 000 Blane Creek ALS23.3 T3 1.0 1 000 (VKIOA2.3 W574L Blane Creek A2 (VKIOA2.2) Ti MSU 0.1 100 Blane Creek ALS23.3 T3 0.1 100 VKI OA2.3 PW Blane Creek ALS7.3 T3 IMI 10 1 000 Blane Creek (KK24A14.4) T3 10 1 000 ALS8.3 (KK18A8) P197S- Blane Creek ALS7.3 T3 CSU 10 10 000 W574L Blane Creek (KK24A14.4) T3 10 10 000 ALS8.3 (KK18A8) P197S- Blane Creek ALS7.3 T3 MSU 1.0 1 000 W574L Blane Creek (KK24A14.4) T3 1.0 1 000 ALS8.3 (KK18A8) A 122T- Blane Creek ALS 11.3 T3 IMI 10 1 000 P197S- Blane Creek K10A5.3 T3 10 1 000 W574L ALS22.3(VK13A1 5.12 A122T- Blane Creek ALS 11.3 T3 CSU 10 10 000 P197S- Blane Creek (VK10A5.3) T3 10 10 000 W574L ALS22.3(VK13A1 5.12 A122T- Blane Creek ALS 11.3 T3 MSU 0.1 100 P197S- Blane Creek (VK10A5.3) T3 1.0 1 000 W574L ALS22.3(VK13A1 5.12 EXAMPLE 5 Herbicide selection Two transformation series were performed to estimate effect of herbicide selection during in vitro regeneration of shoots C. sativa cv. Blane Creek.
Part of explants was cultured without selection. Another part of explants was grown for 5 days without selection and then 3 days 0.01 mg/l IMI. After the 3 days exposure to herbicide the cultivation of explants continued without selection. All recovered shoots were transferred to the MS agar supplied with 0.1 mg/l IMI to ensure the herbicide resistance of the shoots. After 2 -3 weeks of selection, survived shoots were transferred to rooting.
In Table 4 below, the proportion of transgenic shoots (that survived on the second strong selection) is shown in comparison with a number of inoculated explants and all shoots firstly cut from the explants.
We did not take into account vitrificated or weakly survived shoots. Thus the real number of transgenic shoots could be much greater than shown in the table. Therefore it is suggested here, that nucleotide sequences encoding mutated ALS-proteins are beneficial to use for purpose of selection and more specifically for purpose of improving frequency of transgenic plants.
Table 4. Transformation frequencies in two transformation series VK12 and VK13.
VK12 transformation series: 17th March 2009, Blane Creek, constructs: A2 (pCambia0300 Pals-ALS(W574)-Tals), A5 (pCambia0300 Pals-ALS (A122,P197,W574)-Tals) and A8 (pCambia0300 Pals-ALS(P 197, W574)-Tals) VK13 transformation series: 26th March 2009, Blane Creek, constructs: All (pCambia0300 Pals(-TATA)-ALS(W574)-Tals), A13 (pCambia0300 Pals(-TATA)-ALS(A122+P197)-Tals), A14 (pCambia0300 Pals(-TATA)-ALS(P197,W574)-Tals), A15 (pCambia0300 Pals(-TATA)-ALS(A122,P 197,W574)-Tals) Trans- Construct IMI Explants All Resistant Frequency Frequency formation code selection # shoots shoots # % to % to all (mutation) cut # explants shoots VK12A2 A2 (W574) NO 26 40 12 46 30 VK12A2 A5 (A+P+W) NO 21 25 4 19 16 VKI2A2 A8 (P+W) NO 25 42 8 32 19 VK13AII All (W574) NO 23 29 5 21 17 VK13A13 A13 (A+P) NO 21 18 0 0 0 VK13A14 A14 (P+W) NO 19 26 5 26 19 (A+P+W) Total 144 209 34 23.6% 16.3%
Max 46% 30%
Min 0% 0%
VKI2A2 A2 (W574) YES 29 33 14 48 42 VK12A2 AS (A+P+W) YES 22 24 23 104 96 VK12A2 A8 (P+W) YES 23 31 9 39 29 VK13A11 All (W574) YES 27 28 7 26 25 VK13A13 A13 (A+P) YES 30 53 20 67 38 VK13AI4 A14 (P+W) YES 26 40 7 27 18 (A+P+W) Total 183 248 95 51.9% 38.3%
Max 104% 96%
Min 26% 18%
2s
2 l of each RT-reactions was used as template in 20 pl PCR reactions using Dynazyme II polymerase 1 u (Finnzymes) in it's own 1X buffer 100 M dNTPs (-the same amount comes with the template from RT-reactions) 2% DMSO, GUS-5'-F and 250 nM GUS-e2-R primers. Program: 95 C 4 min., 35 X [(95 C, 30 s), (52 C, 20 s), (72 C, 30 s)].
The primers for RT-PCR were designed to match the 103 nucleotide sequence (SEQ
ID NO:14) from transcription terminator region of ALS gene of Papaver rhoeas (which was introduced close downstream of stop codon the mutated Arabidopsis ALS gene specifically for this purpose). Most of the RNA samples produced the right size amplification product confirming the right mRNA expression of foreign ALS gene.
Southern Analysis Total genomic DNA was isolated from leaf tissue of Camelina sativa plants by CTAB extraction and DEAE sepharose purification. Leaf material of 10 transgenic ALS plant lines of cv. Blane Creek of third generation was joined and used for DNA isolation. Southern Analysis was conducted of the samples of transgenic ALS plant lines of third generation:
ALS1.2 (VK12A8.18) ALS2.2 (KK21A14.1.2) ALS3.3 (KK21A14.3) ALS5.1 (VK13A14.1) ALS7.3 (KK24A14.4) ALS8.3 (KK18A8/KK2OA7) ALS9.1 (KK18A8/KK20A7) ALS10.3 (VK12A8.9.1) ALS11.3 (VK10A5.3) ALS22.3 (VK13A15.12) Eight micrograms of total DNA of Camelina sativa plants was digested with Xbal restriction enzyme.
These enzyme cut out 5.8 kb fragment of almost whole T-DNA region. Digested DNA samples were separated in a 0.8% agarose gel in overnight electrophoresis at 9 V and 15 mA
current and transferred to positively charged nylon membrane (Boehringer, Mannheim) using capillary transfer. RNA probes were synthesized using T7 RNA polymerase on the PCR product carrying promoter of Arabidopsis ALS gene and labeled with digoxigenin- 11 -UTP. The membrane was hybridized and developed according to the supplier's instructions (Boehringer, Mannheim, The DIG user's guide for filter hybridization): prehybridized at 50 C. for 2 h and hybridized at 50 C in a "DIG Easy Hyb"
hybridization solution (Boehringer, Mannheim) overnight with a digoxigenin-UTP
labeled RNA probe.
The concentration of RNA probe was 150 ng/ml. After hybridization the membrane was washed in SSC buffers, blocked and detected by using "Anti-Digoxigenin-AP alkaline phosphatase (Boehringer, Mannheim). Chemiluminescent detection was conducted with CSPD-substrate and the membrane was exposed to X-ray film. Presence of the transgene insertion was proved by comparison to DNA of non-transgenic Camelina sativa plant DNA as negative control (line BC + 1kb M), and to plasmid DNA
carrying the gene sequence, cut with restriction enzymes and mixed with non-transgenic plant DNA as positive control (line BC + M) (Fig. 15).
The Xbal cut 5.8 kb fragment contains whole ALS gene including promoter and part of terminator regions. Therefore the right size T-DNA insert should look as one 5.8 kb band in Fig. 15. If one recognition site of the Xbal restriction enzymes absence in the case of defective insert, the size of the detected band should differ 5.8 kb.
As a result of the Southern analysis we can say that all analyzed lines contain right size transgenic insert in the genome (Fig. 15). Plant lines of 1.2; 5.1; 7.3 and 10.3 (columns 1,4,5 and 8 in Fig. 15 respectively) do not contain defective inserts. Lines 2.2; 3.3; 8.3; 9.1; 11.3 and 22.3 (columns 2,3, 6,7,9 and 10 in Fig. 15, respectively) have extra bands caused by additional incomplete insert(s) in the genome.
EXAMPLE 4. Herbicide assays Seedlings of the developed transgenic lines of Camelina sativa, cultivars Blane Creek and Calena second (Ti) and fourth (T3) generations were exposed to various concentration of three herbicides:
imidazolinone (IMI), chlorsulfuron (CSU) and metsulfuron (MSU). Resistance of the transgenic lines was compared to control non-transgenic seedlings of C. sativa cv. Blane Creek.
Seeds were sterilized in 2% Na-hypocloride and placed on wet filter paper in sterile conditions to allow germination. On the next day well-germinated seedlings were transferred on Petri dishes containing MS (Murasige-Scoog) 0.7 % agar (without sucrose or hormones). Each dish contained one from the three herbicides in particular concentration (0.0001, 0.001, 0.01, 0.1, 1.0, 10, 100 mg/1). After one week of cultivation in vitro (+25 C/+18 C; light/dark) the seedlings were photographed (as shown on the figures 16A-16F). The highest survival concentration was found for each transgenic line and for each herbicide and compared to the non-transgenic control. The results are combined in the Table 3.
The results of the bioassay to herbicide resistance showed that:
1. Almost all transgenic lines bearing mutated ALS gene demonstrated increased herbicide resistance.
2. In the best lines resistance increased in 10 000 times as compared to non-transgenic control.
3. Each mutation has own spectrum of resistance. A - specifically increased resistance to IMI, P -to CSU, and W has a good resistance to IMI and CSU and it was less effective to MSU.
4. The best resistance reveals lines bearing double mutations PW: 1 000 - 10 000 increase in resistance to CSU and IMI, and 1 000 increase resistance to MSU.
5. Triple mutation (APW) plants also exhibit a good resistance to all three herbicides.
Table 3. Highest survival concentrations of herbicides for various transgenic lines of C. sativa.
Mutation Cultivar Line Generation Herbicide Highest Effect as surviving compared concentration to control mg/l No Blane Creek Wild type - IMI 0.01 1 No Blane Creek Wild type - CSU 0.001 1 No Blane Creek Wild type - MSU 0.001 1 A122T Calena A3 (VK9A3.4.1) Ti 10 1 000 Blane Creek A9.1 (VK14A9.1) Ti IMI 1.0 100 Slane Creek A9.2 (VK14A9.4.2) Ti 10 1 000 A122T Calena A3 (VK9A3.4.1) Ti 0.01 10 Blane Creek A9.1 (VK14A9.1) Ti CSU 0.001 1 Slane Creek A9.2 (VK14A9.4.2) Ti 0.01 10 A122T Calena A3 (VK9A3.4.1) Ti 0.01 10 Blane Creek A9.1 (VK14A9.1) Ti MSU 0.001 1 Slane Creek A9.2 VK14A9.4.2 Ti 0.001 1 P197S Calena A4 (VK9A4.4.2) Ti IMI 0.1 10 Slane Creek A10 VK14A10.16 Ti 0.1 10 P197S Calena A4 (VK9A4.4.2) Ti CSU 10 10 000 Slane Creek A10 VK14A10.16 Ti 1.0 1 000 P197S Calena A4 (VK9A4.4.2) Ti MSU 0.01 10 Slane Creek A10 VK14A10.16 Ti 0.01 10 W574L Blane Creek A2 (VKIOA2.2) T1 IMI 100 10 000 Blane Creek ALS23.3 T3 10 1 000 VKI OA2.3 W574L Blane Creek A2 (VKIOA2.2) Ti CSU 10 10 000 Blane Creek ALS23.3 T3 1.0 1 000 (VKIOA2.3 W574L Blane Creek A2 (VKIOA2.2) Ti MSU 0.1 100 Blane Creek ALS23.3 T3 0.1 100 VKI OA2.3 PW Blane Creek ALS7.3 T3 IMI 10 1 000 Blane Creek (KK24A14.4) T3 10 1 000 ALS8.3 (KK18A8) P197S- Blane Creek ALS7.3 T3 CSU 10 10 000 W574L Blane Creek (KK24A14.4) T3 10 10 000 ALS8.3 (KK18A8) P197S- Blane Creek ALS7.3 T3 MSU 1.0 1 000 W574L Blane Creek (KK24A14.4) T3 1.0 1 000 ALS8.3 (KK18A8) A 122T- Blane Creek ALS 11.3 T3 IMI 10 1 000 P197S- Blane Creek K10A5.3 T3 10 1 000 W574L ALS22.3(VK13A1 5.12 A122T- Blane Creek ALS 11.3 T3 CSU 10 10 000 P197S- Blane Creek (VK10A5.3) T3 10 10 000 W574L ALS22.3(VK13A1 5.12 A122T- Blane Creek ALS 11.3 T3 MSU 0.1 100 P197S- Blane Creek (VK10A5.3) T3 1.0 1 000 W574L ALS22.3(VK13A1 5.12 EXAMPLE 5 Herbicide selection Two transformation series were performed to estimate effect of herbicide selection during in vitro regeneration of shoots C. sativa cv. Blane Creek.
Part of explants was cultured without selection. Another part of explants was grown for 5 days without selection and then 3 days 0.01 mg/l IMI. After the 3 days exposure to herbicide the cultivation of explants continued without selection. All recovered shoots were transferred to the MS agar supplied with 0.1 mg/l IMI to ensure the herbicide resistance of the shoots. After 2 -3 weeks of selection, survived shoots were transferred to rooting.
In Table 4 below, the proportion of transgenic shoots (that survived on the second strong selection) is shown in comparison with a number of inoculated explants and all shoots firstly cut from the explants.
We did not take into account vitrificated or weakly survived shoots. Thus the real number of transgenic shoots could be much greater than shown in the table. Therefore it is suggested here, that nucleotide sequences encoding mutated ALS-proteins are beneficial to use for purpose of selection and more specifically for purpose of improving frequency of transgenic plants.
Table 4. Transformation frequencies in two transformation series VK12 and VK13.
VK12 transformation series: 17th March 2009, Blane Creek, constructs: A2 (pCambia0300 Pals-ALS(W574)-Tals), A5 (pCambia0300 Pals-ALS (A122,P197,W574)-Tals) and A8 (pCambia0300 Pals-ALS(P 197, W574)-Tals) VK13 transformation series: 26th March 2009, Blane Creek, constructs: All (pCambia0300 Pals(-TATA)-ALS(W574)-Tals), A13 (pCambia0300 Pals(-TATA)-ALS(A122+P197)-Tals), A14 (pCambia0300 Pals(-TATA)-ALS(P197,W574)-Tals), A15 (pCambia0300 Pals(-TATA)-ALS(A122,P 197,W574)-Tals) Trans- Construct IMI Explants All Resistant Frequency Frequency formation code selection # shoots shoots # % to % to all (mutation) cut # explants shoots VK12A2 A2 (W574) NO 26 40 12 46 30 VK12A2 A5 (A+P+W) NO 21 25 4 19 16 VKI2A2 A8 (P+W) NO 25 42 8 32 19 VK13AII All (W574) NO 23 29 5 21 17 VK13A13 A13 (A+P) NO 21 18 0 0 0 VK13A14 A14 (P+W) NO 19 26 5 26 19 (A+P+W) Total 144 209 34 23.6% 16.3%
Max 46% 30%
Min 0% 0%
VKI2A2 A2 (W574) YES 29 33 14 48 42 VK12A2 AS (A+P+W) YES 22 24 23 104 96 VK12A2 A8 (P+W) YES 23 31 9 39 29 VK13A11 All (W574) YES 27 28 7 26 25 VK13A13 A13 (A+P) YES 30 53 20 67 38 VK13AI4 A14 (P+W) YES 26 40 7 27 18 (A+P+W) Total 183 248 95 51.9% 38.3%
Max 104% 96%
Min 26% 18%
2s
Claims (14)
1. A transgenic Camelina sativa plant, said plant being resistant to acetolactate synthase inhibiting herbicides.
2. The plant of claim 1, wherein resistance to acetolactate synthase inhibiting herbicides is achieved by transforming the plant with a construct comprising an ALS natural gene cassette of Arabidopsis thaliana, said gene cassette comprising an ALS promoter, a mutated ALS gene coding region and a terminator region.
3. The plant of claim 2, wherein the mutated coding region comprises one to three point mutations.
4. The plant of claim 3, wherein the mutated ALS gene coding region is according to SEQ ID NO:
24 including one or more point mutations selected from the group consisting of A122T, P197S
and W574L.
24 including one or more point mutations selected from the group consisting of A122T, P197S
and W574L.
5. The plant according to claim 2, 3 or 4 wherein the promoter is according to SEQ ID NO: 9.
6. The plant according to claim 5, wherein TATA-boxes of SEC61 encoding gene are removed by mutation of the promoter region between SacI-PvuI restriction sites.
7. The plant according to claim 6, wherein the promoter is according to SEQ ID
NO: 33.
NO: 33.
8. The plant according to anyone of claim 2, wherein the terminator is according to SEQ ID NO:
10.
10.
9. A transformation cassette for plant transformation to produce transgenic plant resistant to ALS-binding herbicides, said cassette comprising a nucleotide sequence encoding mutated ALS-protein, said mutated ALS gene coding region further being according to SEQ ID
NO: 24 and including one or more point mutations selected from the group consisting of A122T, P197S and W574L.
NO: 24 and including one or more point mutations selected from the group consisting of A122T, P197S and W574L.
10. The transformation cassette according to claim 9, wherein the ALS-encoding nucleotide sequence is operably linked to an ALS promoter according to SEQ ID NO: 9.
11. The transformation cassette according to claim 10, wherein TATA-boxes of SEC61 encoding gene are removed by mutation of the promoter region between SacI-PvuI
restriction sites.
restriction sites.
12. The transformation cassette according to claim 9, wherein ALS-encoding nucleotide sequence is operably linked to an ALS promoter according to SEQ ID NO: 33.
13. A method to improve transformation frequency in in vitro selection, said method comprising:
a) transforming a plant tissue with a construct carrying a nucleotide sequence encoding mutated ALS-protein, and a nucleotide sequence encoding a gene of interest;
b) cultivating the transformed plant tissue in vitro on a medium containing ALS-inhibiting herbicide; and c) growing and rooting recovered shoots.
a) transforming a plant tissue with a construct carrying a nucleotide sequence encoding mutated ALS-protein, and a nucleotide sequence encoding a gene of interest;
b) cultivating the transformed plant tissue in vitro on a medium containing ALS-inhibiting herbicide; and c) growing and rooting recovered shoots.
14. The method of claim 14, wherein the mutated ALS-protein is encoded by a nucleotide sequence according to SEQ ID NO: 24 including one or more point mutations selected from the group consisting of A122T, P197S and W574L.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26871609P | 2009-06-15 | 2009-06-15 | |
| US61/268,716 | 2009-06-15 | ||
| PCT/US2010/001704 WO2010147636A1 (en) | 2009-06-15 | 2010-06-15 | Herbicide resistant camelina sativa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2758247A1 true CA2758247A1 (en) | 2010-12-23 |
Family
ID=43356665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2758247A Abandoned CA2758247A1 (en) | 2009-06-15 | 2010-06-15 | Herbicide resistant camelina sativa |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP2458973A4 (en) |
| AU (1) | AU2010260518A1 (en) |
| CA (1) | CA2758247A1 (en) |
| WO (1) | WO2010147636A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160208277A1 (en) * | 2013-08-21 | 2016-07-21 | Bayer Cropscience Nv | Als inhibitor herbicide tolerant mutant plants |
| WO2020140146A1 (en) * | 2019-01-02 | 2020-07-09 | Linnaeus Plant Sciences Inc. | Herbicide-resistant camelina sativa plants, and variant camelina acetohydroxyacid synthase polypeptides |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI110009B (en) * | 2000-11-13 | 2002-11-15 | Unicrop Ltd | A transformation system in Camelina sativa |
| US20090151023A1 (en) * | 2000-11-13 | 2009-06-11 | Viktor Kuvshinov | Transformation system for Camelina sativa |
| EP1917360A2 (en) * | 2005-08-24 | 2008-05-07 | Pioneer Hi-Bred International Inc. | Compositions providing tolerance to multiple herbicides and methods of use thereof |
| DE102005053318A1 (en) * | 2005-11-07 | 2007-05-10 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Process for increasing the total oil content in oil plants |
| WO2007149069A2 (en) * | 2006-06-15 | 2007-12-27 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Resistance to acetolactate synthase-inhibiting herbicides |
-
2010
- 2010-06-15 AU AU2010260518A patent/AU2010260518A1/en not_active Abandoned
- 2010-06-15 CA CA2758247A patent/CA2758247A1/en not_active Abandoned
- 2010-06-15 WO PCT/US2010/001704 patent/WO2010147636A1/en not_active Ceased
- 2010-06-15 EP EP10789853.8A patent/EP2458973A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010260518A1 (en) | 2011-11-03 |
| EP2458973A1 (en) | 2012-06-06 |
| EP2458973A4 (en) | 2013-05-01 |
| WO2010147636A1 (en) | 2010-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12203082B2 (en) | Genetic control of axillary bud growth in tobacco plants | |
| Barthakur et al. | Over-expression of osmotin induces proline accumulation and confers tolerance to osmotic stress in transgenic tobacco | |
| JP6530887B2 (en) | Agrobacterium strain modified to increase plant transformation rate | |
| TW201720928A (en) | Potato Cultivar X17 | |
| EP4032976A1 (en) | Mutant hydroxyphenylpyruvate dioxygenase polypeptide, encoding gene thereof and use thereof | |
| CN110881367A (en) | Corn event Ttrans-4 and methods of use thereof | |
| US20060090219A1 (en) | Methods for producing plants with improved growth under nitrogen-limited conditions | |
| US20170002374A1 (en) | Materials, systems, organisms, and methods for enhancing abiotic stress tolerance, increasing biomass, and/or altering lignin composition | |
| US9139841B2 (en) | Plant having resistance to low-temperature stress and method of production thereof | |
| RU2451079C2 (en) | Acetolactate synthase herbicide resistant sorghum | |
| CN102176817A (en) | Environmentally adjusted transgenic plants | |
| JP2012507263A (en) | Glutamate decarboxylase (GAD) transgenic plants exhibiting altered plant structure | |
| CA2758247A1 (en) | Herbicide resistant camelina sativa | |
| JP4394490B2 (en) | Genes that confer salt stress tolerance | |
| US20050235379A1 (en) | Development of controlled total vegetative growth for prevention of transgene escape from genetically modified plants and for enhancing biomass production | |
| JP5804420B2 (en) | Genes involved in promotion of plant growth and increase in biomass and methods for using the same | |
| US20130117887A1 (en) | Herbicide resistant Camelina Sativa | |
| US9365862B1 (en) | Herbicide resistant sorghum mutants | |
| JP5648822B2 (en) | Modification of rice anthranilate synthase using homologous recombination | |
| WO2021061830A1 (en) | Herbicide resistant plants and methods of making and using | |
| JP4953050B2 (en) | Plant node-specific gene expression promoter and use thereof | |
| TR2025014454A2 (en) | Development of Tolerance to ALS Inhibitor Class Herbicides in Carrot (Daucus Carota L.) Using Genome Editing Technology | |
| KR20250076416A (en) | Corn plant having herbicide-tolerance trait by EPSPs gene base-editing and producing method thereof | |
| JP2006034252A (en) | Combined environmental stress tolerance rice | |
| CN117511960A (en) | Salt-tolerant gene ZmPCP1 and encoding protein and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20160615 |